Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
bupropion hydrobromide
|
| gptkbp:approvalYear |
2008
|
| gptkbp:associatedWith |
gptkb:Wellbutrin
gptkb:Zyban |
| gptkbp:ATCCode |
N06AX12
|
| gptkbp:chemicalFormula |
C13H18ClNO•HBr
|
| gptkbp:contraindication |
eating disorder
seizure disorder abrupt discontinuation of alcohol |
| gptkbp:drugClass |
antidepressant
norepinephrine reuptake inhibitor |
| gptkbp:form |
extended-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aplenzin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Bausch_Health
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:regulates |
approved
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache insomnia dry mouth |
| gptkbp:usedFor |
gptkb:depression
gptkb:major_depressive_disorder |
| gptkbp:bfsParent |
gptkb:Bausch_Health_Companies_Inc.
gptkb:Wellbutrin_XL gptkb:Wellbutrin gptkb:Zyban |
| gptkbp:bfsLayer |
7
|